Erica Muniz
Family · Wellington, FLNPI 1578236196
Payments from drug & device makers
Across 294 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$857
- Sanofi-aventis U.S. LLC$676
- Novo Nordisk$660
- Medtronic$641
- Xeris Pharmaceuticals, Inc.$588
- AbbVie$404
- plus $2K from 27 others
What the payments were for
- Travel & lodging$3937%
- Food & beverage$5,28993%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 45 | $857 |
| Sanofi-aventis U.S. LLC | 28 | $676 |
| Novo Nordisk | 58 | $660 |
| Medtronic | 13 | $641 |
| Xeris Pharmaceuticals, Inc. | 35 | $588 |
| AbbVie | 19 | $404 |
| E.r. Squibb & Sons, L.L.C. | 21 | $359 |
| Dexcom, Inc. | 12 | $246 |
| Corcept Therapeutics | 10 | $192 |
| Boehringer Ingelheim | 10 | $192 |
| Amneal Pharmaceuticals LLC | 9 | $137 |
| Atricure, Inc. | 1 | $124 |
| Abbott | 4 | $65 |
| AstraZeneca | 3 | $60 |
| Vivus LLC | 3 | $55 |
| Antares Pharma, Inc. | 3 | $54 |
| Radius Health, Inc. | 2 | $43 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Acella Pharmaceuticals, LLC | 2 | $35 |
| Nevro Corp. | 1 | $27 |
| Lifescan, Inc. | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Zealand Pharma US, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,706 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 98 | $157,152 |
| OzempicSemaglutide | 88 | $136,881 |
| JardianceEmpagliflozin | 38 | $59,469 |
| JanuviaSitagliptin Phosphate | 48 | $48,672 |
| Tresiba Flextouch U-100Insulin Degludec | 29 | $29,271 |
| TrulicityDulaglutide | 21 | $25,411 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 15 | $16,398 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 17 | $12,302 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $11,843 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 12 | $11,583 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $10,837 |
| Novolog FlexpenInsulin Aspart | 14 | $5,796 |
| SynthroidLevothyroxine Sodium | 40 | $4,833 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 33 | $4,615 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 12 | $3,664 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $857 | $182,563119 claims |
| Novo NordiskOzempic | $660 | $136,88188 claims |
| Boehringer IngelheimJardiance | $192 | $59,46938 claims |
| MerckJanuvia | $15 | $48,67248 claims |
| AbbVieSynthroid | $404 | $4,83340 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $137 | $1,397123 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $35 | $42411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Wellington
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.